17alpha-ethynylestradiol increases expression ISO RGD:1312710 6480464 Ethinyl Estradiol results in increased expression of AIFM2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1312710 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1312709 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of AIFM2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312710 6480464 Tetrachlorodibenzodioxin affects the expression of AIFM2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312710 6480464 Tetrachlorodibenzodioxin results in decreased expression of AIFM2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312710 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312709 6480464 Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA CTD PMID:20106945 , PMID:21632981 2,6-di-tert-butyl-4-methylphenol multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [ganglioside more ... CTD PMID:14987999 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1312710 6480464 3 more ... CTD PMID:19467301 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1312710 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA CTD PMID:24848799 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1312710 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of AIFM2 exon, bis(4-hydroxyphenyl)sulfone results in decreased methylation of AIFM2 promoter CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312710 6480464 Fenretinide results in decreased expression of AIFM2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of AIFM2 mRNA CTD PMID:24780913 acrylamide increases expression ISO RGD:1312709 6480464 Acrylamide results in increased expression of AIFM2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of AIFM2 mRNA CTD PMID:33354967 aldrin decreases expression ISO RGD:1312710 6480464 Aldrin results in decreased expression of AIFM2 mRNA CTD PMID:18579281 aristolochic acid A increases expression ISO RGD:1312709 6480464 aristolochic acid I results in increased expression of AIFM2 mRNA CTD PMID:33212167 benzo[a]pyrene increases expression ISO RGD:1312709 6480464 Benzo(a)pyrene results in increased expression of AIFM2 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene affects methylation ISO RGD:1312709 6480464 Benzo(a)pyrene affects the methylation of AIFM2 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1312709 6480464 Benzo(a)pyrene results in increased methylation of AIFM2 5' UTR CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AIFM2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1312709 6480464 bisphenol A results in decreased expression of AIFM2 protein CTD PMID:33376534 bisphenol A multiple interactions ISO RGD:1312709 6480464 [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of AIFM2 protein] CTD PMID:33376534 bisphenol A affects expression ISO RGD:1312709 6480464 bisphenol A affects the expression of AIFM2 mRNA CTD PMID:30903817 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of AIFM2 promoter CTD PMID:27415467 bortezomib increases expression ISO RGD:1312709 6480464 Bortezomib results in increased expression of AIFM2 mRNA CTD PMID:20977926 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of AIFM2 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:1312710 6480464 Cadmium results in decreased expression of AIFM2 mRNA CTD PMID:24067728 cadmium atom multiple interactions ISO RGD:1312709 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:1312709 6480464 Cadmium Chloride results in decreased expression of AIFM2 mRNA CTD PMID:25596134 cadmium dichloride multiple interactions ISO RGD:1312709 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA CTD PMID:35301059 cadmium sulfide increases expression ISO RGD:1312709 6480464 cadmium sulfide results in increased expression of AIFM2 mRNA CTD PMID:27866839 CGP 52608 multiple interactions ISO RGD:1312709 6480464 CGP 52608 promotes the reaction [RORA protein binds to AIFM2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1312710 6480464 Chlordecone results in increased expression of AIFM2 mRNA CTD PMID:33711761 chloroacetaldehyde increases expression ISO RGD:1312709 6480464 chloroacetaldehyde results in increased expression of AIFM2 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1312709 6480464 Cisplatin results in decreased expression of AIFM2 mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1312709 6480464 Cisplatin results in increased expression of AIFM2 mRNA, Cisplatin results in increased expression of AIFM2 protein CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1312709 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AIFM2 mRNA more ... CTD PMID:27392435 clodronic acid affects expression ISO RGD:1312709 6480464 Clodronic Acid affects the expression of AIFM2 mRNA CTD PMID:25596134 cobalt dichloride increases expression ISO RGD:1312709 6480464 cobaltous chloride results in increased expression of AIFM2 mRNA CTD PMID:19320972 cocaine affects expression ISO RGD:1312710 6480464 Cocaine affects the expression of AIFM2 mRNA CTD PMID:15681117 copper atom multiple interactions ISO RGD:1312709 6480464 [NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1312709 6480464 [NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1312709 6480464 Copper Sulfate results in increased expression of AIFM2 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of AIFM2 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1312709 6480464 Cyclosporine results in increased expression of AIFM2 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of AIFM2 mRNA CTD PMID:25596134 dexamethasone increases expression ISO RGD:1312709 6480464 Dexamethasone results in increased expression of AIFM2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1312710 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA CTD PMID:24848799 dibenz[a,h]anthracene increases expression ISO RGD:1312710 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of AIFM2 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1312710 6480464 Dichloroacetic Acid results in increased expression of AIFM2 mRNA CTD PMID:28962523 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of AIFM2 mRNA CTD PMID:22546817 dioxygen decreases expression ISO RGD:1312709 6480464 Oxygen deficiency results in decreased expression of AIFM2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1312709 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of AIFM2 mRNA CTD PMID:19915844 endosulfan increases expression ISO RGD:1312709 6480464 Endosulfan results in increased expression of AIFM2 mRNA CTD PMID:26722802 epoxiconazole decreases expression ISO RGD:1312710 6480464 epoxiconazole results in decreased expression of AIFM2 mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1312710 6480464 Ethanol affects the expression of AIFM2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1312709 6480464 Ethyl Methanesulfonate results in increased expression of AIFM2 mRNA CTD PMID:23649840 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of AIFM2 mRNA CTD PMID:25596134 fenofibrate increases expression ISO RGD:1312709 6480464 Fenofibrate results in increased expression of AIFM2 mRNA CTD PMID:25596134 fulvestrant increases methylation ISO RGD:1312709 6480464 Fulvestrant results in increased methylation of AIFM2 gene CTD PMID:31601247 hydrogen peroxide multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein] CTD PMID:14987999 hydrogen peroxide affects expression ISO RGD:1312709 6480464 Hydrogen Peroxide affects the expression of AIFM2 mRNA CTD PMID:20044591 hydrogen peroxide increases secretion EXP 6480464 Hydrogen Peroxide results in increased secretion of AIFM2 protein CTD PMID:14987999 hydroquinone increases expression ISO RGD:1312709 6480464 hydroquinone results in increased expression of AIFM2 mRNA CTD PMID:31256213 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of AIFM2 mRNA CTD PMID:25596134 ibuprofen increases expression ISO RGD:1312709 6480464 Ibuprofen results in increased expression of AIFM2 mRNA CTD PMID:25596134 metformin decreases expression EXP 6480464 Metformin results in decreased expression of AIFM2 mRNA CTD PMID:25596134 methotrexate affects expression ISO RGD:1312710 6480464 Methotrexate affects the expression of AIFM2 mRNA CTD PMID:18502557 methyl methanesulfonate increases expression ISO RGD:1312709 6480464 Methyl Methanesulfonate results in increased expression of AIFM2 mRNA CTD PMID:23649840 methylglyoxal increases expression ISO RGD:1312709 6480464 Pyruvaldehyde results in increased expression of AIFM2 mRNA CTD PMID:30447388 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of AIFM2 mRNA CTD PMID:22546817 paracetamol decreases expression ISO RGD:1312709 6480464 Acetaminophen results in decreased expression of AIFM2 mRNA CTD PMID:25704631 , PMID:26690555 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AIFM2 mRNA CTD PMID:19162173 phenylmercury acetate increases expression ISO RGD:1312709 6480464 Phenylmercuric Acetate results in increased expression of AIFM2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1312709 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1312710 6480464 pirinixic acid results in increased expression of AIFM2 mRNA CTD PMID:18301758 more ... pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of AIFM2 mRNA CTD PMID:19162173 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of AIFM2 mRNA CTD PMID:19013527 SB 431542 multiple interactions ISO RGD:1312709 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1312709 6480464 sodium arsenite results in increased expression of AIFM2 mRNA CTD PMID:21281968 , PMID:25493608 sulindac increases expression ISO RGD:1312709 6480464 Sulindac results in increased expression of AIFM2 mRNA CTD PMID:11906190 sunitinib decreases expression ISO RGD:1312709 6480464 Sunitinib results in decreased expression of AIFM2 mRNA CTD PMID:31533062 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of AIFM2 mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1312710 6480464 titanium dioxide results in decreased expression of AIFM2 mRNA CTD PMID:23557971 tributylstannane increases expression ISO RGD:1312710 6480464 tributyltin results in increased expression of AIFM2 mRNA CTD PMID:24848799 trichloroethene increases expression ISO RGD:1312710 6480464 Trichloroethylene results in increased expression of AIFM2 mRNA CTD PMID:25549359 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of AIFM2 mRNA CTD PMID:25596134 urethane decreases expression ISO RGD:1312709 6480464 Urethane results in decreased expression of AIFM2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312710 6480464 Valproic Acid affects the expression of AIFM2 mRNA CTD PMID:17292431 
